"We can confirm that Novo Nordisk has filed a lawsuit against Mylan for patent infringement of Victoza," the company said in an e-mail.
The news was first reported by Bloomberg.
(Reporting by Andreas Mortensen; editing by Jason Neely)
COPENHAGEN (Reuters) - Novo Nordisk said on Thursday it has filed litigation in a Delaware district court against Mylan aimed at blocking its attempt to market a generic version of the Danish insulin maker's drug Victoza.
"We can confirm that Novo Nordisk has filed a lawsuit against Mylan for patent infringement of Victoza," the company said in an e-mail.
The news was first reported by Bloomberg.
(Reporting by Andreas Mortensen; editing by Jason Neely)
1st Jan change | Capi. | |
---|---|---|
+29.68% | 699B | |
+25.07% | 571B | |
-4.35% | 364B | |
+17.65% | 326B | |
+3.77% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.79% | 154B |